Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01917968 · ClinicalTrials.gov registry record · NA
Uphold LITE Post-Market Surveillance Study
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 289
- Enrollment target
NCT01917968 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 289 participants.
The verdict
NCT01917968, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 289 participants
- Enrollment target
Study Summary
The purpose of this study is to compare transvaginal mesh repair to traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse.
Interventions
- DEVICE Uphold Lightweight Vaginal Support System
- PROCEDURE Traditional native tissue repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2013-10-10 |
| Est. Completion | 2020-02-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01917968
The ClinicalTrials.gov registry entry for NCT01917968 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Uphold Lightweight Vaginal Support System is the first listed.
NCT01917968 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01917968 about?
NCT01917968 is a clinical study titled "Uphold LITE Post-Market Surveillance Study". The purpose of this study is to compare transvaginal mesh repair to traditional native tissue repair in women surgically treated for anterior and/or apical pelvic organ prolapse.
What is the current status of trial NCT01917968?
This trial is currently completed. It is a NA study. The enrollment target is 289 participants. The study started on 2013-10-10. Estimated completion is 2020-02-12.
What interventions are being tested in trial NCT01917968?
The interventions under investigation include: Uphold Lightweight Vaginal Support System (DEVICE), Traditional native tissue repair (PROCEDURE).
Who is sponsoring clinical trial NCT01917968?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.